Research output per year
Research output per year
Personal profile
Education
- 國立成功大學臨床醫學研究所碩士
Experience
- 2016年08月 ~迄今 胃腸肝膽科醫師
- 2015年10月 ~2016年07月 健康管理中心醫師
- 2015年01月 ~2015年09月 健康與國際醫療中心醫師
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Po-Jun Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 6 Article
-
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
Wu, J. S., Hong, T. C., Wu, H-T., Lin, Y. J., Chang, T. T., Wang, C. T., Liu, W-C., Hsieh, M. T., Wu, I-C., Chen, P. J., Chen, C. Y., Lin, S-H., Chuang, C. H., Han, M. Z., Chen, H. P., Tsai, H-M. & Kuo, H. Y., 2023 Apr 29, In: Journal of Gastrointestinal Oncology. 14, 2, p. 849-862 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
Chiang, H. C., Lee, Y. C., Chang, T. T., Lin, Y. J., Wu, H. T., Wang, C. T., Chen, C. Y., Chen, P. J., Hsieh, M. T., Lin, S. H., Chen, S. H., Chuang, C. H., Wu, I. C., Hong, T. C., Wu, J. S., Han, M. Z., Chen, W. T., Chiang, C. M., Hung, K. K. & Kuo, H. Y., 2023 Feb, In: Cancers. 15, 3, 854.Research output: Contribution to journal › Article › peer-review
Open Access -
Age, male sex, smoking and metabolic syndrome as risk factors of advanced colorectal neoplasia for fecal immunochemical test negative patients
Cheng, W. C., Chen, P. J., Kang, J. W., Chen, W. Y. & Sheu, B. S., 2022 Jan, In: Journal of the Formosan Medical Association. 121, 1, p. 402-408 7 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
Kuo, H. Y., Han, M. Z., Liao, C. H., Lin, Y. J., Wang, C. T., Chen, S. H., Chang, T. T., Chen, P. J., Lin, S. H., Chen, C. Y., Chuang, C. H., Wu, I. C., Wu, J. S., Hong, T. C., Hsieh, M. T., Lee, Y. C., Wu, H. T. & Tsai, H. M., 2022 Nov, In: Pharmaceutics. 14, 11, 2263.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
Tsai, H. M., Han, M. Z., Lin, Y. J., Chang, T. T., Chen, C. Y., Cheng, P. N., Chuang, C. H., Wu, I. C., Chen, P. J., Kang, J. W., Chiu, Y. C., Chiu, H. C., Chien, S. C. & Kuo, H. Y., 2021 Jul, In: Cancer Immunology, Immunotherapy. 70, 7, p. 1929-1937 9 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Citations (Scopus)